HBx-Derived Constrained Peptides Inhibit the Secretion of Hepatitis B Virus Antigens-Reference-Cited by-同舟云学术

HBx-Derived Constrained Peptides Inhibit the Secretion of Hepatitis B Virus Antigens

Published:2018-10-30 Issue:12 Volume:15 Page:5646-5652
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Cai Xiaodan¹,Zheng Weihao¹²,Shi Xiaodong¹,Chen Longjian¹,Liu Zhihong¹,Li Zigang¹^ORCID

Affiliation:

1. State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China

2. Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94110, United States

Funder

National Natural Science Foundation of China

Shenzhen Science and Technology Innovation Committee

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00807

Reference66 articles.

1. An In-tether Chiral Center Modulates the Helicity, Cell Permeability, and Target Binding Affinity of a Peptide

2. General approach to the synthesis of short .alpha.-helical peptides

3. Multicyclic polypeptide model compounds. 1. Synthesis of a tricyclic amphiphilic .alpha.-helical peptide using an oxime resin, segment-condensation approach

4. An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides

5. Single Turn Peptide Alpha Helices with Exceptional Stability in Water

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Metal-Free Peptide Stapling Strategies;Chem & Bio Engineering;2024-06-11

2. Therapeutic stapled peptides: Efficacy and molecular targets;Pharmacological Research;2024-05

3. Stapled peptides: targeting protein-protein interactions in drug development;Exploration of Drug Science;2024-04-18

4. Stapled peptides for new drug discovery;Privileged Scaffolds in Drug Discovery;2023

5. E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation;Antiviral Research;2021-08